The genetic disorder cystic fibrosis is unique ... of individuals cannot benefit from modulators due to their genetic mutations or ability to tolerate the treatment," says Boyle.

These include pharmaceutical treatments such as CFTR (cystic fibrosis transmembrane conductance regulator) modulators, enzyme replacement therapies, and antibiotics for respiratory infections. In ...

Cystic fibrosis (CF) treatment typically involves procedures and medications that help clear the airways. Other treatments may include antibiotics, pancreatic enzymes, a high-calorie diet, and newer ...

A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey towards seeing this treatment in the clinic. For this first phase ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis ... respond well to relatively new treatments known as CFTR modulator medicines, which work by ...

(Reuters) - Vertex Pharmaceuticals forecast annual revenue largely above Wall Street estimates on Monday, banking on robust sales of its cystic fibrosis drugs and early contributions from a newly ...

The drugmaker is looking to its acute pain drug, Journavx, to drive growth beyond its established line of cystic fibrosis treatments. Vertex expects to begin shipping Journavx to pharmacies in the ...

Racial disparities in lung transplantation rates in CF suggest that HEMT has benefitted White patients more than Black and Hispanic patients.